Vianovatx
Oakland, US · Founded 2020 · Delaware corporation · 2 known investors
Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
Founders & leadership
DG
Donald GanemNamed on SEC filing
BL
Benjamine LiuNamed on SEC filing
IZ
Ilan ZipkinNamed on SEC filing
Board
JJ

Investors · 2
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2021
▶$5MraisedSep 2021 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedSep 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald GanemExecutive Officer, Director
- Joseph JimenezDirector
- Benjamine LiuDirector
- Ilan ZipkinDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapVianova SAS6 shared keywordsVianova operates a cloud-based intelligence platform that aggregates and combines mobility data from multiple sources, letting cities and businesses analyze insights and automate decisions. It also runs a data exchange with over 1,000 mobility data sources and offers integration, project management, and advisory services for urban mobility use cases.
Osmosis6 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Medscape6 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Companies competing with Vianovatx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vianovatx do?
- Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
- Who are Vianovatx's investors?
- Vianovatx's investors include Aditum Bio, PMV.
- How much funding has Vianovatx raised?
- Vianovatx has disclosed $5M raised across 1 round.
- Where is Vianovatx headquartered?
- Vianovatx is headquartered in Oakland, US.
